Vutrisiran Shows Sustained Benefits in Cardiac Amyloidosis ...Middle East

Medscape - News
Vutrisiran Shows Sustained Benefits in Cardiac Amyloidosis
Vutrisiran can improve and maintain functional capacity and quality of life in patients with transthyretin amyloidosis with cardiomyopathy, according to a follow-up analysis of data from the HELIOS-B trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Vutrisiran Shows Sustained Benefits in Cardiac Amyloidosis )

Also on site :



Latest News